Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 580673, 12 pages
http://dx.doi.org/10.1155/2013/580673
Research Article

Matrine Inhibits Infiltration of the Inflammatory Monocyte Subset in Injured Mouse Liver through Inhibition of Monocyte Chemoattractant Protein-1

Department of Biochemical Pharmacy, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China

Received 26 March 2013; Revised 19 June 2013; Accepted 17 July 2013

Academic Editor: Evan Paul Cherniack

Copyright © 2013 Duo Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Friedman, “Liver fibrosis—from bench to bedside,” Journal of Hepatology, Supplement, vol. 38, no. 1, pp. S38–S53, 2003. View at Google Scholar · View at Scopus
  2. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Winwood and M. J. P. Arthur, “Kupffer cells: Their activation and role in animal models of liver injury and human liver disease,” Seminars in Liver Disease, vol. 13, no. 1, pp. 50–59, 1993. View at Google Scholar · View at Scopus
  5. Y. Shiratori, A. Geerts, and T. Ichida, “Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells,” Journal of Hepatology, vol. 3, no. 3, pp. 294–303, 1986. View at Google Scholar · View at Scopus
  6. S. L. Friedman and M. J. P. Arthur, “Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors,” Journal of Clinical Investigation, vol. 84, no. 6, pp. 1780–1785, 1989. View at Google Scholar · View at Scopus
  7. M. Matsuoka and H. Tsukamoto, “Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis,” Hepatology, vol. 11, no. 4, pp. 599–605, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Heymann, C. Trautwein, and F. Tacke, “Monocytes and macrophages as cellular targets in liver fibrosis,” Inflammation and Allergy, vol. 8, no. 4, pp. 307–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Imamura, T. Ogawa, Y. Sasaguri, K. Chayama, and H. Ueno, “Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats,” Gastroenterology, vol. 128, no. 1, pp. 138–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Gordon and P. R. Taylor, “Monocyte and macrophage heterogeneity,” Nature Reviews Immunology, vol. 5, no. 12, pp. 953–964, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Geissmann, S. Jung, and D. R. Littman, “Blood monocytes consist of two principal subsets with distinct migratory properties,” Immunity, vol. 19, no. 1, pp. 71–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Sunderkötter, T. Nikolic, M. J. Dillon et al., “Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response,” Journal of Immunology, vol. 172, no. 7, pp. 4410–4417, 2004. View at Google Scholar · View at Scopus
  13. F. Tacke, D. Alvarez, T. J. Kaplan et al., “Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. A. Kuziel, S. J. Morgan, T. C. Dawson et al., “Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 22, pp. 12053–12058, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhou, Y. Yang, G. Warr, and R. Bravo, “LPS down-regulates the expression of chemokine receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation,” Journal of Leukocyte Biology, vol. 65, no. 2, pp. 265–269, 1999. View at Google Scholar · View at Scopus
  16. L. Boring, J. Gosling, S. W. Chensue et al., “Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice,” Journal of Clinical Investigation, vol. 100, no. 10, pp. 2552–2561, 1997. View at Google Scholar · View at Scopus
  17. T. Kurihara, G. Warr, J. Loy, and R. Bravo, “Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor,” Journal of Experimental Medicine, vol. 186, no. 10, pp. 1757–1762, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. K. R. Karlmark, R. Weiskirchen, H. W. Zimmermann et al., “Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis,” Hepatology, vol. 50, no. 1, pp. 261–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Gregory, E. F. Morand, S. J. McKeown et al., “Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2,” Journal of Immunology, vol. 177, no. 11, pp. 8072–8079, 2006. View at Google Scholar · View at Scopus
  20. R. E. Gerszten, E. A. Garcia-Zepeda, Y.-C. Lim et al., “MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions,” Nature, vol. 398, no. 6729, pp. 718–725, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Czaja, A. Geerts, J. Xu, P. Schmiedeberg, and Y. Ju, “Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease,” Journal of Leukocyte Biology, vol. 55, no. 1, pp. 120–126, 1994. View at Google Scholar · View at Scopus
  22. F. Marra, R. DeFranco, C. Grappone et al., “Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration,” American Journal of Pathology, vol. 152, no. 2, pp. 423–430, 1998. View at Google Scholar · View at Scopus
  23. M. Liu, X. Y. Liu, and J. F. Cheng, “Advance in the pharmacological research on matrine,” China Journal of Chinese Materia Medica, vol. 28, no. 9, pp. 801–804, 2003. View at Google Scholar
  24. J.-Y. Liu, J.-H. Hu, Q.-G. Zhu, F.-Q. Li, J. Wang, and H.-J. Sun, “Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts,” International Immunopharmacology, vol. 7, no. 6, pp. 816–823, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Zhang, Z.-Y. Liu, Y.-Y. Li et al., “Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice,” European Journal of Pharmaceutical Sciences, vol. 44, no. 5, pp. 573–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Zhang, X. Wang, L. Tong et al., “Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia/reperfusion in rats,” Surgery Today, vol. 41, no. 8, pp. 1075–1084, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Suo, Y. Liu, M. Ferreri et al., “Impact of matrine on inflammation related factors in rat intestinal microvascular endothelial cells,” Journal of Ethnopharmacology, vol. 125, no. 3, pp. 404–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Z.-L. Lei, X.-J. Liu, J.-X. Ma, and J. Zhu, “Effects of matrine on airway inflammation and early airway remodeling in asthmatic mice,” Chinese Journal of Tuberculosis and Respiratory Diseases, vol. 32, no. 3, pp. 165–170, 2009. View at Google Scholar · View at Scopus
  29. C. Y. Chuang, J. G. Xiao, and G. C. Y. Chiou, “Ocular anti-inflammatory actions of matrine,” Journal of Ocular Pharmacology, vol. 3, no. 2, pp. 129–134, 1987. View at Google Scholar · View at Scopus
  30. J.-P. Zhang, M. Zhang, J.-P. Zhou et al., “Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats,” Acta Pharmacologica Sinica, vol. 22, no. 2, pp. 183–186, 2001. View at Google Scholar · View at Scopus
  31. X. Zhao, Q. Kan, L. Zhu, and G.-X. Zhang, “Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis,” American Journal of Chinese Medicine, vol. 39, no. 5, pp. 933–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Cheng, B. Xia, L. Zhang et al., “Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice,” Pharmacological Research, vol. 53, no. 3, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Lin, J. P. Zhang, Z. L. Hu, and D. H. Qian, “Inhibitory effect of matrine on lipopolysacchride-induced tumor necrosis factor and interleukin-6 production from rat Kupffer cells,” Acta Pharmaceutica Sinica, vol. 32, no. 2, pp. 93–96, 1997. View at Google Scholar · View at Scopus
  34. Z.-L. Hu, J.-P. Zhang, X.-B. Yu, W. Lin, D.-H. Qian, and M.-B. Wan, “Effect of matrine on lipopolysaccharides/D-galactosamine-induced hepatitis and tumor necrosis factor release from macrophages in vitro,” Acta Pharmacologica Sinica, vol. 17, no. 4, pp. 351–353, 1996. View at Google Scholar · View at Scopus
  35. V. G. Pillarisetty, A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo, “Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition,” Journal of Immunology, vol. 172, no. 2, pp. 1009–1017, 2004. View at Google Scholar · View at Scopus
  36. D. Vrochides, V. Papanikolaou, H. Pertoft, A. A. Antoniades, and P. Heldin, “Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration,” Hepatology, vol. 23, no. 6, pp. 1650–1655, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Leifeld, F.-L. Dumoulin, I. Purr et al., “Early up-regulation of chemokine expression in fulminant hepatic failure,” Journal of Pathology, vol. 199, no. 3, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Marra, A. J. Valente, M. Pinzani, and H. E. Abboud, “Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines,” Journal of Clinical Investigation, vol. 92, no. 4, pp. 1674–1680, 1993. View at Google Scholar · View at Scopus
  39. Y. Xu, M. Rojkind, and M. J. Czaja, “Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells,” Gastroenterology, vol. 110, no. 6, pp. 1870–1877, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-W. Zhang and Y. Jin, “Renoprotective effects of matrine on experimental glomerulosclerosis in rats,” Chinese Journal of Pediatrics, vol. 42, no. 10, pp. 737–740, 2004. View at Google Scholar · View at Scopus
  41. H.-Y. Gao, G.-Y. Li, M.-M. Lou, X.-Y. Li, X.-Y. Wei, and J.-H. Wang, “Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis,” Journal of Inflammation, vol. 9, article 16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. L. Hu, J. P. Zhang, M. B. Wan, X. B. Yu, W. Lin, and D. H. Qian, “Effect of matrine on mouse hepatitis and tumor necrosis factor production induced by propionibacterium acnes/lipopolysaccharides,” Acta Pharmaceutica Sinica, vol. 31, no. 9, pp. 662–665, 1996. View at Google Scholar · View at Scopus
  43. M. Parola and G. Robino, “Oxidative stress-related molecules and liver fibrosis,” Journal of Hepatology, vol. 35, no. 2, pp. 297–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. J. S. Duffield, S. J. Forbes, C. M. Constandinou et al., “Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair,” Journal of Clinical Investigation, vol. 115, no. 1, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. N. V. Serbina and E. G. Pamer, “Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2,” Nature Immunology, vol. 7, no. 3, pp. 311–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. D. R. Engel, J. Maurer, A. P. Tittel et al., “CCR2 mediates homeostatic and inflammatory release of Gr1high monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection,” Journal of Immunology, vol. 181, no. 8, pp. 5579–5586, 2008. View at Google Scholar · View at Scopus
  47. E. Zamara, S. Galastri, S. Aleffi et al., “Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice,” Journal of Hepatology, vol. 46, no. 2, pp. 230–238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Sakai, T. Wada, K. Furuichi et al., “MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes,” Journal of Leukocyte Biology, vol. 79, no. 3, pp. 555–563, 2006. View at Publisher · View at Google Scholar · View at Scopus